MPL mutations in MPN patients have traditionally been characterized using melting curve assays combined with Sanger sequencing [12], [13], quantitative-PCR [14], [15], or, more recently, deep sequencing [16], [17]. This evidence concerns the gene MPL and myeloproliferative disorder.